JP2019537439A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019537439A5 JP2019537439A5 JP2019522907A JP2019522907A JP2019537439A5 JP 2019537439 A5 JP2019537439 A5 JP 2019537439A5 JP 2019522907 A JP2019522907 A JP 2019522907A JP 2019522907 A JP2019522907 A JP 2019522907A JP 2019537439 A5 JP2019537439 A5 JP 2019537439A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- primer
- adapter
- double
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 claims description 128
- 150000007523 nucleic acids Chemical class 0.000 claims description 128
- 102000039446 nucleic acids Human genes 0.000 claims description 128
- 238000000034 method Methods 0.000 claims description 103
- 125000003729 nucleotide group Chemical group 0.000 claims description 55
- 239000002773 nucleotide Substances 0.000 claims description 52
- 238000003786 synthesis reaction Methods 0.000 claims description 31
- 230000000295 complement effect Effects 0.000 claims description 27
- 238000003752 polymerase chain reaction Methods 0.000 claims description 13
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- 230000003321 amplification Effects 0.000 claims description 11
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 11
- 201000011510 cancer Diseases 0.000 claims description 10
- 230000005298 paramagnetic effect Effects 0.000 claims description 9
- 102000003960 Ligases Human genes 0.000 claims description 8
- 108090000364 Ligases Proteins 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 8
- 229960002685 biotin Drugs 0.000 claims description 8
- 239000011616 biotin Substances 0.000 claims description 8
- 230000036210 malignancy Effects 0.000 claims description 8
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 7
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 7
- 238000009396 hybridization Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 238000004458 analytical method Methods 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 6
- 238000012986 modification Methods 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 108091008875 B cell receptors Proteins 0.000 claims description 5
- 108091008874 T cell receptors Proteins 0.000 claims description 5
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 5
- 108010090804 Streptavidin Proteins 0.000 claims description 4
- 210000000265 leukocyte Anatomy 0.000 claims description 4
- 238000012163 sequencing technique Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- AUTOLBMXDDTRRT-JGVFFNPUSA-N (4R,5S)-dethiobiotin Chemical compound C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O AUTOLBMXDDTRRT-JGVFFNPUSA-N 0.000 claims description 2
- HRFIATJPGFXBNN-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;2-[2-(2-hydroxyethoxy)ethoxy]ethanol Chemical compound OCCOCCOCCO.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 HRFIATJPGFXBNN-UFLZEWODSA-N 0.000 claims description 2
- BUVSBIKCBLHNCG-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;azide Chemical compound [N-]=[N+]=[N-].N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 BUVSBIKCBLHNCG-UFLZEWODSA-N 0.000 claims description 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 2
- 241000251556 Chordata Species 0.000 claims description 2
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 2
- 108700005091 Immunoglobulin Genes Proteins 0.000 claims description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 2
- 206010025323 Lymphomas Diseases 0.000 claims description 2
- 208000034578 Multiple myelomas Diseases 0.000 claims description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
- 239000011324 bead Substances 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims description 2
- 230000028993 immune response Effects 0.000 claims description 2
- 108020004999 messenger RNA Proteins 0.000 claims description 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 1
- 238000000137 annealing Methods 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000003100 immobilizing effect Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 230000008439 repair process Effects 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 238000012412 chemical coupling Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical class O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical class C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 108091008915 immune receptors Proteins 0.000 description 1
- 102000027596 immune receptors Human genes 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022166273A JP7483824B2 (ja) | 2016-11-02 | 2022-10-17 | 免疫レパートリーシーケンシングのための核酸サンプル調製の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662416677P | 2016-11-02 | 2016-11-02 | |
| US62/416,677 | 2016-11-02 | ||
| PCT/US2017/059804 WO2018085599A2 (en) | 2016-11-02 | 2017-11-02 | Methods of nucleic acid sample preparation for immune repertoire sequencing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022166273A Division JP7483824B2 (ja) | 2016-11-02 | 2022-10-17 | 免疫レパートリーシーケンシングのための核酸サンプル調製の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019537439A JP2019537439A (ja) | 2019-12-26 |
| JP2019537439A5 true JP2019537439A5 (enExample) | 2020-12-17 |
| JP7161991B2 JP7161991B2 (ja) | 2022-10-27 |
Family
ID=62077010
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522907A Active JP7161991B2 (ja) | 2016-11-02 | 2017-11-02 | 免疫レパートリーシーケンシングのための核酸サンプル調製の方法 |
| JP2022166273A Active JP7483824B2 (ja) | 2016-11-02 | 2022-10-17 | 免疫レパートリーシーケンシングのための核酸サンプル調製の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022166273A Active JP7483824B2 (ja) | 2016-11-02 | 2022-10-17 | 免疫レパートリーシーケンシングのための核酸サンプル調製の方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10947582B2 (enExample) |
| EP (2) | EP3535405B1 (enExample) |
| JP (2) | JP7161991B2 (enExample) |
| CN (1) | CN110191959B (enExample) |
| AU (2) | AU2017355460B2 (enExample) |
| CA (1) | CA3042391A1 (enExample) |
| ES (1) | ES2940620T3 (enExample) |
| WO (1) | WO2018085599A2 (enExample) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2905448T3 (es) | 2012-05-10 | 2022-04-08 | Massachusetts Gen Hospital | Métodos para determinar una secuencia nucleotídica |
| WO2014066179A1 (en) * | 2012-10-24 | 2014-05-01 | Clontech Laboratories, Inc. | Template switch-based methods for producing a product nucleic acid |
| CN106661612A (zh) | 2014-01-27 | 2017-05-10 | 通用医疗公司 | 制备用于测序的核酸的方法 |
| DK3901281T4 (da) | 2015-04-10 | 2025-10-20 | Illumina Inc | Rumligt adskilt, multipleks nukleinsyreanalyse af biologiske prøver |
| US10683531B2 (en) | 2016-09-15 | 2020-06-16 | ArcherDX, Inc. | Methods of nucleic acid sample preparation for analysis of cell-free DNA |
| CA3037185A1 (en) | 2016-09-15 | 2018-03-22 | ArcherDX, Inc. | Methods of nucleic acid sample preparation |
| US20220282305A1 (en) * | 2016-09-15 | 2022-09-08 | Archerdx, Llc | Methods of nucleic acid sample preparation |
| CA3042391A1 (en) * | 2016-11-02 | 2018-05-11 | ArcherDX, Inc. | Methods of nucleic acid sample preparation for immune repertoire sequencing |
| US12188014B1 (en) * | 2018-07-25 | 2025-01-07 | 10X Genomics, Inc. | Compositions and methods for nucleic acid processing using blocking agents |
| US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
| WO2020123320A2 (en) | 2018-12-10 | 2020-06-18 | 10X Genomics, Inc. | Imaging system hardware |
| US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
| EP3969583A1 (en) * | 2019-05-14 | 2022-03-23 | F. Hoffmann-La Roche AG | Devices and methods for sample analysis |
| WO2020243579A1 (en) | 2019-05-30 | 2020-12-03 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
| CN111139286B (zh) * | 2019-11-07 | 2023-11-21 | 南方医科大学南方医院 | 一种bcr高通量测序文库的构建方法 |
| WO2021092433A2 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
| EP4667585A2 (en) | 2019-12-23 | 2025-12-24 | 10X Genomics, Inc. | Methods for spatial analysis using rna-templated ligation |
| CN115038794A (zh) | 2019-12-23 | 2022-09-09 | 10X基因组学有限公司 | 在基于分区的测定中使用固定生物样品的组合物和方法 |
| US12365942B2 (en) | 2020-01-13 | 2025-07-22 | 10X Genomics, Inc. | Methods of decreasing background on a spatial array |
| US12405264B2 (en) | 2020-01-17 | 2025-09-02 | 10X Genomics, Inc. | Electrophoretic system and method for analyte capture |
| US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
| US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
| US20210230681A1 (en) | 2020-01-24 | 2021-07-29 | 10X Genomics, Inc. | Methods for spatial analysis using proximity ligation |
| US12076701B2 (en) | 2020-01-31 | 2024-09-03 | 10X Genomics, Inc. | Capturing oligonucleotides in spatial transcriptomics |
| US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
| US12110541B2 (en) | 2020-02-03 | 2024-10-08 | 10X Genomics, Inc. | Methods for preparing high-resolution spatial arrays |
| US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
| WO2021158925A1 (en) | 2020-02-07 | 2021-08-12 | 10X Genomics, Inc. | Quantitative and automated permeabilization performance evaluation for spatial transcriptomics |
| US12281357B1 (en) | 2020-02-14 | 2025-04-22 | 10X Genomics, Inc. | In situ spatial barcoding |
| US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
| EP4139485B1 (en) | 2020-04-22 | 2023-09-06 | 10X Genomics, Inc. | Methods for spatial analysis using targeted rna depletion |
| WO2021237087A1 (en) | 2020-05-22 | 2021-11-25 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
| WO2021236929A1 (en) | 2020-05-22 | 2021-11-25 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
| WO2021242834A1 (en) | 2020-05-26 | 2021-12-02 | 10X Genomics, Inc. | Method for resetting an array |
| EP4600376A3 (en) * | 2020-06-02 | 2025-10-22 | 10X Genomics, Inc. | Spatial transcriptomics for antigen-receptors |
| AU2021283174A1 (en) | 2020-06-02 | 2023-01-05 | 10X Genomics, Inc. | Nucleic acid library methods |
| US12031177B1 (en) | 2020-06-04 | 2024-07-09 | 10X Genomics, Inc. | Methods of enhancing spatial resolution of transcripts |
| WO2021252499A1 (en) | 2020-06-08 | 2021-12-16 | 10X Genomics, Inc. | Methods of determining a surgical margin and methods of use thereof |
| EP4165207B1 (en) | 2020-06-10 | 2024-09-25 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
| AU2021294334A1 (en) | 2020-06-25 | 2023-02-02 | 10X Genomics, Inc. | Spatial analysis of DNA methylation |
| US12209280B1 (en) | 2020-07-06 | 2025-01-28 | 10X Genomics, Inc. | Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis |
| US11981960B1 (en) | 2020-07-06 | 2024-05-14 | 10X Genomics, Inc. | Spatial analysis utilizing degradable hydrogels |
| US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
| US11981958B1 (en) | 2020-08-20 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using DNA capture |
| US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
| CN112266962B (zh) * | 2020-11-13 | 2021-04-30 | 苏州科贝生物技术有限公司 | 一种联合检测急性淋巴细胞白血病的试剂盒 |
| US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
| AU2021409136A1 (en) | 2020-12-21 | 2023-06-29 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
| EP4305196B1 (en) | 2021-04-14 | 2025-04-02 | 10X Genomics, Inc. | Methods of measuring mislocalization of an analyte |
| WO2022236054A1 (en) | 2021-05-06 | 2022-11-10 | 10X Genomics, Inc. | Methods for increasing resolution of spatial analysis |
| WO2022256503A1 (en) | 2021-06-03 | 2022-12-08 | 10X Genomics, Inc. | Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis |
| EP4196605B1 (en) | 2021-09-01 | 2024-12-04 | 10X Genomics, Inc. | Methods for blocking a capture probe on a spatial array |
| WO2023086880A1 (en) | 2021-11-10 | 2023-05-19 | 10X Genomics, Inc. | Methods, compositions, and kits for determining the location of an analyte in a biological sample |
| WO2023102118A2 (en) | 2021-12-01 | 2023-06-08 | 10X Genomics, Inc. | Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5374524A (en) | 1988-05-10 | 1994-12-20 | E. I. Du Pont De Nemours And Company | Solution sandwich hybridization, capture and detection of amplified nucleic acids |
| US5827658A (en) | 1996-08-09 | 1998-10-27 | The United States Of America As Reprsented By The Department Of Health And Human Services | Isolation of amplified genes via cDNA subtractive hybridization |
| US7074556B2 (en) * | 1999-03-02 | 2006-07-11 | Invitrogen Corporation | cDNA synthesis improvements |
| US6818395B1 (en) | 1999-06-28 | 2004-11-16 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
| US6309836B1 (en) | 1999-10-05 | 2001-10-30 | Marek Kwiatkowski | Compounds for protecting hydroxyls and methods for their use |
| WO2001083696A2 (en) | 2000-04-28 | 2001-11-08 | Digital Gene Tech Inc | Methods for rapid isolation and sequence determination of gene-specific sequences |
| DK1454992T3 (da) | 2003-03-07 | 2006-10-02 | Ist Naz Stud Cura Dei Tumori | Anaplastisk lymfomakinaseassay, reagenser og sammensætninger deraf |
| US7226720B2 (en) | 2003-09-08 | 2007-06-05 | General Electric Company | Limited play data storage media and method for limiting access to data thereon |
| US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| ES2527118T3 (es) | 2003-12-19 | 2015-01-20 | Plexxikon Inc. | Compuestos y procedimientos de desarrollo de moduladores de Ret |
| TWI311152B (en) * | 2004-09-17 | 2009-06-21 | Boehringer Ingelheim Rcv Gmbh & Co K | Host-vector system for antibiotic-free cole1 plasmid propagation |
| GB0421525D0 (en) | 2004-09-28 | 2004-10-27 | Novartis Ag | Inhibitors of protein kineses |
| US20070070349A1 (en) | 2005-09-23 | 2007-03-29 | Helicos Biosciences Corporation | Optical train and method for TIRF single molecule detection and analysis |
| US7220549B2 (en) | 2004-12-30 | 2007-05-22 | Helicos Biosciences Corporation | Stabilizing a nucleic acid for nucleic acid sequencing |
| GB0522310D0 (en) * | 2005-11-01 | 2005-12-07 | Solexa Ltd | Methods of preparing libraries of template polynucleotides |
| US7282337B1 (en) | 2006-04-14 | 2007-10-16 | Helicos Biosciences Corporation | Methods for increasing accuracy of nucleic acid sequencing |
| WO2009032167A1 (en) | 2007-08-29 | 2009-03-12 | Illumina Cambridge | Method for sequencing a polynucleotide template |
| WO2010006432A1 (en) | 2008-07-14 | 2010-01-21 | Queen's University At Kingston | Pharmaceutical compositions comprising ret inhibitors and methods for the treatment of cancer |
| US9416409B2 (en) | 2009-07-31 | 2016-08-16 | Ibis Biosciences, Inc. | Capture primers and capture sequence linked solid supports for molecular diagnostic tests |
| EP2848704B1 (en) | 2010-01-19 | 2018-08-29 | Verinata Health, Inc | Sequencing methods for prenatal diagnoses |
| EP2606154B1 (en) | 2010-08-20 | 2019-09-25 | Integenx Inc. | Integrated analysis system |
| US8722585B2 (en) | 2011-05-08 | 2014-05-13 | Yan Wang | Methods of making di-tagged DNA libraries from DNA or RNA using double-tagged oligonucleotides |
| CN103717751A (zh) * | 2011-05-19 | 2014-04-09 | 塞昆纳姆股份有限公司 | 用于多重核酸鉴定的产品和方法 |
| CA2862552A1 (en) * | 2012-01-26 | 2013-08-01 | Nugen Technologies, Inc. | Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation |
| ES2905448T3 (es) * | 2012-05-10 | 2022-04-08 | Massachusetts Gen Hospital | Métodos para determinar una secuencia nucleotídica |
| WO2014008447A1 (en) | 2012-07-03 | 2014-01-09 | Integrated Dna Technologies, Inc. | Tm-enhanced blocking oligonucleotides and baits for improved target enrichment and reduced off-target selection |
| AU2013325107C1 (en) | 2012-09-25 | 2019-02-28 | Agriculture Victoria Services Pty Ltd | Method of producing a normalised nucleic acid library using solid state capture material |
| EP2959016A4 (en) * | 2013-02-21 | 2016-10-12 | Toma Biosciences Inc | METHOD, COMPOSITIONS AND NUCLEIC ACID ANALYSIS KITS |
| CA2905517C (en) * | 2013-03-15 | 2024-11-12 | Lineage Biosciences, Inc. | METHODS AND COMPOSITIONS FOR LABELING AND ANALYZING SAMPLES |
| US10119134B2 (en) * | 2013-03-15 | 2018-11-06 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| AU2014361815A1 (en) | 2013-12-15 | 2016-05-26 | Academia Sinica | Methods for full-length amplification of double-stranded linear nucleic acids of unknown sequences |
| CN106661612A (zh) | 2014-01-27 | 2017-05-10 | 通用医疗公司 | 制备用于测序的核酸的方法 |
| US20150211061A1 (en) * | 2014-01-27 | 2015-07-30 | The General Hospital Corporation | Methods for determining a nucleotide sequence |
| US9738897B2 (en) * | 2014-06-23 | 2017-08-22 | Regeneron Pharmaceuticals, Inc. | Nuclease-mediated DNA assembly |
| MX378730B (es) * | 2014-09-15 | 2025-03-11 | Abvitro Llc | Secuenciacion de bibliotecas de nucleotidos de alto rendimiento |
| CN107208157B (zh) | 2015-02-27 | 2022-04-05 | 贝克顿迪金森公司 | 用于条形编码核酸以用于测序的方法和组合物 |
| JP6847496B2 (ja) * | 2015-08-06 | 2021-03-24 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 単一プローブプライマー伸長による標的濃縮 |
| CA3020814A1 (en) * | 2016-04-15 | 2017-10-19 | University Health Network | Hybrid-capture sequencing for determining immune cell clonality |
| CA3037185A1 (en) | 2016-09-15 | 2018-03-22 | ArcherDX, Inc. | Methods of nucleic acid sample preparation |
| US10683531B2 (en) | 2016-09-15 | 2020-06-16 | ArcherDX, Inc. | Methods of nucleic acid sample preparation for analysis of cell-free DNA |
| CA3042391A1 (en) * | 2016-11-02 | 2018-05-11 | ArcherDX, Inc. | Methods of nucleic acid sample preparation for immune repertoire sequencing |
-
2017
- 2017-11-02 CA CA3042391A patent/CA3042391A1/en active Pending
- 2017-11-02 AU AU2017355460A patent/AU2017355460B2/en active Active
- 2017-11-02 US US15/802,408 patent/US10947582B2/en active Active
- 2017-11-02 JP JP2019522907A patent/JP7161991B2/ja active Active
- 2017-11-02 EP EP17868046.8A patent/EP3535405B1/en active Active
- 2017-11-02 WO PCT/US2017/059804 patent/WO2018085599A2/en not_active Ceased
- 2017-11-02 CN CN201780080046.0A patent/CN110191959B/zh active Active
- 2017-11-02 EP EP22209186.0A patent/EP4198140B1/en active Active
- 2017-11-02 ES ES17868046T patent/ES2940620T3/es active Active
-
2021
- 2021-02-17 US US17/177,740 patent/US20210180118A1/en not_active Abandoned
-
2022
- 2022-10-17 JP JP2022166273A patent/JP7483824B2/ja active Active
-
2023
- 2023-03-06 AU AU2023201370A patent/AU2023201370B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019537439A5 (enExample) | ||
| JP7483824B2 (ja) | 免疫レパートリーシーケンシングのための核酸サンプル調製の方法 | |
| US20240229105A1 (en) | Attenuators | |
| JP2023040233A (ja) | 分子の多重検出方法 | |
| US11293048B2 (en) | Attenuators | |
| JP2021010388A (ja) | 細胞の選択された部分集団中の複数エピトープを識別するための方法 | |
| JP2017510244A5 (enExample) | ||
| JP2018524993A5 (enExample) | ||
| JP7539770B2 (ja) | ゲノム再編成検出のための配列決定方法 | |
| JPWO2021092386A5 (enExample) | ||
| JP2023513606A (ja) | 核酸を評価するための方法および材料 | |
| EP2494069A2 (en) | Method for detecting balanced chromosomal aberrations in a genome | |
| JP2017514478A (ja) | 集積した単一細胞の配列決定 | |
| CN114616329A (zh) | 从OLIGO-DT逆转录RNA中回收TCRα和β链VDJ的探针捕获方法 | |
| JP4286243B2 (ja) | プローブセットを設計する方法、それによって設計されたプローブが固定化された基板を有するマイクロアレイ及び該方法をコンピュータで実行可能なプログラムとして記録したコンピュータで読み取り可能な記録媒体 | |
| JPWO2020167656A5 (enExample) | ||
| JP7610617B2 (ja) | 反応混合物からの過剰なオリゴヌクレオチドの除去 | |
| US20250263777A1 (en) | Methods for sequencing long polynucleotides | |
| KR100844010B1 (ko) | 다중 유전자 동시 증폭방법 | |
| KR20060073815A (ko) | 변형된 ｒｃａ 및 2차 프라이머에 의한 핵산 증폭 방법 | |
| KR20180095357A (ko) | cDNA 또는 앰플리콘 및 이를 담지한 담체를 포함하는 구조체 |